Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Grimminger

Showing results (1-10 of 334) with videos related to

Pageof 34
Sort By:
Critical Reviews in Immunology|January 1, 2004
Endothelial responses to bacterial toxins in sepsisUlrich Grandel, Friedrich Grimminger
Advances in Experimental Medicine and Biology|March 6, 2010
PDGF receptor and its antagonists: role in treatment of PAHFriedrich Grimminger, Ralph Theo Schermuly
Handbook of Experimental Pharmacology|December 18, 2008
Modulating cGMP to treat lung diseasesHossein-Ardeschir Ghofrani, Friedrich Grimminger
The European Respiratory Journal|March 7, 2015
The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosisFriedrich Grimminger, Andreas Günther, Carlo Vancheri
Pulmonary Circulation|February 2, 2013
Smoking: Is it a risk factor for pulmonary vascular diseases?Norbert Weissmann, Friedrich Grimminger, Werner Seeger
Cardiovascular Research|August 4, 2006
Hypoxia in lung vascular biology and diseaseNorbert Weissmann, Friedrich Grimminger, Werner Seeger
The New England Journal of Medicine|September 30, 2005
Imatinib for the treatment of pulmonary arterial hypertensionHossein A Ghofrani, Werner Seeger, Friedrich Grimminger
Circulation|October 22, 2008
Pulmonary vascular disease in the developing worldGhazwan Butrous, Hossein Ardeschir Ghofrani, Friedrich Grimminger
Cardiovascular Research|December 9, 2003
The tantalizing triplet of pulmonary hypertension-BMP receptors, serotonin receptors, and angiopoietinsOliver Eickelberg, Michael E Yeager, Friedrich Grimminger
Nature Reviews. Drug Discovery|December 2, 2010
Targeting non-malignant disorders with tyrosine kinase inhibitorsFriedrich Grimminger, Ralph T Schermuly, Hossein A Ghofrani
Pageof 34

Showing results (1-10 of 334) with videos related to

Sort By:
Pageof 34
Critical Reviews in Immunology|January 1, 2004
Endothelial responses to bacterial toxins in sepsisUlrich Grandel, Friedrich Grimminger
Advances in Experimental Medicine and Biology|March 6, 2010
PDGF receptor and its antagonists: role in treatment of PAHFriedrich Grimminger, Ralph Theo Schermuly
Handbook of Experimental Pharmacology|December 18, 2008
Modulating cGMP to treat lung diseasesHossein-Ardeschir Ghofrani, Friedrich Grimminger
The European Respiratory Journal|March 7, 2015
The role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosisFriedrich Grimminger, Andreas Günther, Carlo Vancheri
Pulmonary Circulation|February 2, 2013
Smoking: Is it a risk factor for pulmonary vascular diseases?Norbert Weissmann, Friedrich Grimminger, Werner Seeger
Cardiovascular Research|August 4, 2006
Hypoxia in lung vascular biology and diseaseNorbert Weissmann, Friedrich Grimminger, Werner Seeger
The New England Journal of Medicine|September 30, 2005
Imatinib for the treatment of pulmonary arterial hypertensionHossein A Ghofrani, Werner Seeger, Friedrich Grimminger
Circulation|October 22, 2008
Pulmonary vascular disease in the developing worldGhazwan Butrous, Hossein Ardeschir Ghofrani, Friedrich Grimminger
Cardiovascular Research|December 9, 2003
The tantalizing triplet of pulmonary hypertension-BMP receptors, serotonin receptors, and angiopoietinsOliver Eickelberg, Michael E Yeager, Friedrich Grimminger
Nature Reviews. Drug Discovery|December 2, 2010
Targeting non-malignant disorders with tyrosine kinase inhibitorsFriedrich Grimminger, Ralph T Schermuly, Hossein A Ghofrani
Pageof 34